Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FemPulse gets FDA approval to test a new vaginal device for overactive bladder in women.

flag FemPulse has received FDA approval to begin a clinical trial for its new device designed to treat overactive bladder in women. flag The wearable device, inserted vaginally, aims to provide continuous nerve stimulation as an alternative to medication. flag If successful, it could offer a new treatment option for millions of women suffering from OAB. flag The company is also seeking regulatory approval in Europe for the device.

3 Articles

Further Reading